I am thrilled to announce that I will be joining @FoxChaseCancer in Philadelphia as an Assistant Professor this fall! My lab will focus on the study of tumor immunity and the tumor microenvironment to ultimately improve immunotherapies in lung cancer. Recruiting at all levels!
Super excited that our paper is out in @CellReports! We show that spliceosome inhibitors trigger ZBP1-driven necroptosis in small cell lung cancer #SCLC enhancing immunotherapy responses! #CañadasLab! @FoxChaseCancer https://t.co/e4TFHie5Wy
In the Spotlight: Loss of p53 Induces Tolerance to Viral Mimicry as a Mechanism of Immune Evasion in Early Tumorigenesis https://t.co/E5EardOuCV
By Takahiko Murayama and @Isra_canadas#CañadasLab@FoxChaseCancer@CeiFccc
Amazing Keynote Session at the 14th Annual Symposium @FoxChaseCancer by Dr. Avram Hershko, 2004 Nobel Prize in Chemistry. Inspiring to hear the incredible story behind the discovery of ubiquitin-mediated protein degradation at Fox Chase!
A discovery by Fox Chase Cancer Center scientists is a step toward understanding why an aggressive cancer is so resistant to treatment. Read more from corresponding study author Israel Cañadas, PhD (@Isra_canadas): https://t.co/7aRv0jEl4G
In honor of Hispanic Heritage Month, we present The Atlas of Inspiring Hispanic/Latinx Scientists. This resource showcases the scientific excellence of nearly 400 outstanding scientists. #LatinxAtlas#HispanicHeritageMonth
https://t.co/f9VAR8mJoK
Very happy to have our TREX1 story finally out! @CRC_AACR Here, we identified TREX1 as a promising new target to induce innate immune responses in #chemoresistant Small Cell Lung Cancer #SCLC@FoxChaseCancer@CeiFccc https://t.co/SHGBUon9Vl